2 recruiting, 1 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Completed 1 |
Follow Adrenal Cortical Cancer: new trials by email Literature Review of Adrenal Cortical Cancer trials Research Report on Adrenal Cortical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma Camrelizumab, Apatinib, mitotane - Adrenal Cortical Carcinoma, Adrenal Cortical Cancer | Phase 2 | Recruiting | West China Hospital | 28 | 2025-03-15 | 2025-06-03 |
| Ivonescimab in the Treatment of Multiple Advanced Tumors Ivocizumab - Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma | Phase 2 | Recruiting | Fudan University | 400 | 2024-11-20 | 2025-08-24 |
| Spectroscopy With Surface Coils and Decoupling Proton-decoupled 31P MRS at 1.5T, 1H Spectroscopy at 1.5T and 3T - Adrenal Cortical Cancer, Brain Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 582 | 1997-02-01 | 2015-12-28 |
Kidney Neoplasms (2) · Prostatic Neoplasms (2) · Sarcoma (2) · Adrenal Gland Neoplasms (1) · Adrenocortical Carcinoma (1) · Angiomyolipoma (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma (1) · Carcinoma, Basal Cell (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Squamous Cell (1) · Carcinoma, Transitional Cell (1) · Central Nervous System Neoplasms (1) · Colonic Neoplasms (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Glandular and Epithelial (3) · Adenocarcinoma (2) · Carcinoma (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Kidney Diseases (2) · Male Urogenital Diseases (2)
Mitotane (1) · apatinib (1) · camrelizumab (1)
Fudan University (1) · Memorial Sloan Kettering Cancer Center (1) · West China Hospital (1)
China (2) · United States (1)
Hongxia Wang, Doctor (1) · Jason Koutcher, MD, PhD (1)